Martin-Villalba A - Search Results

1

Yes and PI3K bind CD95 to signal invasion of glioblastoma.

Kleber S, Sancho-Martinez I, Wiestler B, Beisel A, Gieffers C, Hill O, Thiemann M, Mueller W, Sykora J, Kuhn A, Schreglmann N, Letellier E, Zuliani C, Klussmann S, Teodorczyk M, Gröne HJ, Ganten TM, Sültmann H, Tüttenberg J, von Deimling A, Regnier-Vigouroux A, Herold-Mende C, Martin-Villalba A. Kleber S, et al. Cancer Cell. 2008 Mar;13(3):235-48. doi: 10.1016/j.ccr.2008.02.003. Cancer Cell. 2008. PMID: 18328427 Free article.

2

Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke.

Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH. Martin-Villalba A, et al. Cell Death Differ. 2001 Jul;8(7):679-86. doi: 10.1038/sj.cdd.4400882. Cell Death Differ. 2001. PMID: 11464212

3

Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury.

Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C, Hirt UA, Walczak H, Falk W, Essig M, Edler L, Krammer PH, Martin-Villalba A. Demjen D, et al. Nat Med. 2004 Apr;10(4):389-95. doi: 10.1038/nm1007. Epub 2004 Mar 7. Nat Med. 2004. PMID: 15004554

4

Control of neuronal branching by the death receptor CD95 (Fas/Apo-1).

Zuliani C, Kleber S, Klussmann S, Wenger T, Kenzelmann M, Schreglmann N, Martinez A, del Rio JA, Soriano E, Vodrazka P, Kuner R, Groene HJ, Herr I, Krammer PH, Martin-Villalba A. Zuliani C, et al. Cell Death Differ. 2006 Jan;13(1):31-40. doi: 10.1038/sj.cdd.4401720. Cell Death Differ. 2006. PMID: 16003386

5

Molecular targets in spinal cord injury.

Klussmann S, Martin-Villalba A. Klussmann S, et al. J Mol Med (Berl). 2005 Sep;83(9):657-71. doi: 10.1007/s00109-005-0663-3. Epub 2005 Aug 2. J Mol Med (Berl). 2005. PMID: 16075258 Review.

6

Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth.

Jennemann R, Sandhoff R, Wang S, Kiss E, Gretz N, Zuliani C, Martin-Villalba A, Jäger R, Schorle H, Kenzelmann M, Bonrouhi M, Wiegandt H, Gröne HJ. Jennemann R, et al. Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12459-64. doi: 10.1073/pnas.0500893102. Epub 2005 Aug 18. Proc Natl Acad Sci U S A. 2005. PMID: 16109770 Free PMC article.

7

Manganese-enhanced magnetic resonance imaging for in vivo assessment of damage and functional improvement following spinal cord injury in mice.

Stieltjes B, Klussmann S, Bock M, Umathum R, Mangalathu J, Letellier E, Rittgen W, Edler L, Krammer PH, Kauczor HU, Martin-Villalba A, Essig M. Stieltjes B, et al. Magn Reson Med. 2006 May;55(5):1124-31. doi: 10.1002/mrm.20888. Magn Reson Med. 2006. PMID: 16602070 Free article.

8

The evolution of our understanding on glioma.

Martin-Villalba A, Okuducu AF, von Deimling A. Martin-Villalba A, et al. Brain Pathol. 2008 Jul;18(3):455-63. doi: 10.1111/j.1750-3639.2008.00136.x. Epub 2008 Mar 26. Brain Pathol. 2008. PMID: 18371180 Free PMC article. Review.

9

TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia.

Mora R, Abschuetz A, Kees T, Dokic I, Joschko N, Kleber S, Geibig R, Mosconi E, Zentgraf H, Martin-Villalba A, Régnier-Vigouroux A. Mora R, et al. Glia. 2009 Apr 1;57(5):561-81. doi: 10.1002/glia.20785. Glia. 2009. PMID: 18942750

10

Tyrosine phosphorylation and CD95: a FAScinating switch.

Sancho-Martinez I, Martin-Villalba A. Sancho-Martinez I, et al. Cell Cycle. 2009 Mar 15;8(6):838-42. doi: 10.4161/cc.8.6.7906. Epub 2009 Mar 22. Cell Cycle. 2009. PMID: 19221505 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page